- Concept UI
- M0001326
- Registry Numbers
- 0
- Scope Note
- Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.
- Terms
-
Anti-Arrhythmia Agents
Preferred Term
Term UI
T002584
Date01/01/1999
LexicalTag
NON
ThesaurusID
NLM (1976)
-
Anti-Arrhythmia Drugs
Term UI
T002586
Date10/24/1994
LexicalTag
NON
ThesaurusID
NLM (1996)
-
Anti-Arrhythmics
Term UI
T002587
Date07/19/1994
LexicalTag
NON
ThesaurusID
NLM (1996)
-
Antiarrhythmia Agents
Term UI
T002585
Date01/22/1995
LexicalTag
NON
ThesaurusID
NLM (1996)
-
Antiarrhythmia Drugs
Term UI
T002588
Date01/22/1995
LexicalTag
NON
ThesaurusID
NLM (1996)
-
Antiarrhythmic Drugs
Term UI
T002589
Date10/24/1994
LexicalTag
NON
ThesaurusID
NLM (1996)
-
Anti-Arrhythmia Agent
Term UI
T000997534
Date11/19/2019
LexicalTag
NON
ThesaurusID
NLM (2021)
-
Anti-Arrhythmia Drug
Term UI
T000997535
Date11/19/2019
LexicalTag
NON
ThesaurusID
NLM (2021)
-
Antiarrhythmia Agent
Term UI
T000997536
Date11/19/2019
LexicalTag
NON
ThesaurusID
NLM (2021)
-
Antiarrhythmia Drug
Term UI
T000997537
Date11/19/2019
LexicalTag
NON
ThesaurusID
NLM (2021)
-
Anti-Arrhythmic
Term UI
T000997533
Date11/19/2019
LexicalTag
NON
ThesaurusID
NLM (2021)
-
Antiarrhythmic Drug
Term UI
T000997538
Date11/19/2019
LexicalTag
NON
ThesaurusID
NLM (2021)